Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099450 · ClinicalTrials.gov registry record · Phase 1
Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers
A Phase 1 study, sponsored by Merck Sharp & Dohme.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT00099450 is a Phase 1 study that has completed, run by Merck Sharp & Dohme. The registered enrollment target is 48 participants.
The verdict
NCT00099450, a Phase 1 study, has completed, sponsored by Merck Sharp & Dohme.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The objectives of this study are to look at the safety and tolerability of the experimental drug, how people process the drug, how the drug affects people, and to identify a dose or doses to study in subsequent future studies.
Interventions
- DRUG INS50589 Intravenous Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00099450
The ClinicalTrials.gov registry entry for NCT00099450 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INS50589 Intravenous Infusion is the first listed.
NCT00099450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00099450 about?
NCT00099450 is a clinical study titled "Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers". The objectives of this study are to look at the safety and tolerability of the experimental drug, how people process the drug, how the drug affects people, and to identify a dose or doses to study in subsequent future studies.
What is the current status of trial NCT00099450?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2004-12. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00099450?
The interventions under investigation include: INS50589 Intravenous Infusion (DRUG).
Who is sponsoring clinical trial NCT00099450?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.